BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,874 | -43.2% | 2,046,517 | 0.0% | 0.25% | -21.2% |
| Q2 2023 | $10,335 | +232.1% | 2,046,517 | +24.3% | 0.32% | +73.0% |
| Q1 2023 | $3,112 | +5.0% | 1,646,517 | 0.0% | 0.18% | +12.1% |
| Q4 2022 | $2,964 | -99.9% | 1,646,517 | 0.0% | 0.16% | +38.7% |
| Q3 2022 | $2,783,000 | -31.3% | 1,646,517 | 0.0% | 0.12% | -44.9% |
| Q2 2022 | $4,050,000 | -11.2% | 1,646,517 | 0.0% | 0.22% | +13.1% |
| Q1 2022 | $4,561,000 | -48.0% | 1,646,517 | 0.0% | 0.19% | -19.7% |
| Q4 2021 | $8,776,000 | -37.0% | 1,646,517 | 0.0% | 0.24% | -23.7% |
| Q3 2021 | $13,930,000 | -30.6% | 1,646,517 | 0.0% | 0.31% | -23.3% |
| Q2 2021 | $20,071,000 | -49.8% | 1,646,517 | 0.0% | 0.41% | -42.4% |
| Q1 2021 | $39,945,000 | -24.3% | 1,646,517 | 0.0% | 0.71% | -37.7% |
| Q4 2020 | $52,771,000 | +14.7% | 1,646,517 | +8.2% | 1.13% | +1.4% |
| Q3 2020 | $45,995,000 | -29.5% | 1,521,517 | -1.6% | 1.12% | -38.8% |
| Q2 2020 | $65,201,000 | +54.0% | 1,546,517 | -8.8% | 1.82% | +2.0% |
| Q1 2020 | $42,328,000 | – | 1,696,517 | – | 1.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $104,289,000 | 4.42% |
| Boxer Capital, LLC | 2,014,858 | $60,909,000 | 2.10% |
| RA Capital Management | 2,589,904 | $78,293,000 | 1.43% |
| Artal Group S.A. | 1,521,517 | $45,995,000 | 1.12% |
| Ikarian Capital, LLC | 358,941 | $10,851,000 | 0.78% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 802,511 | $24,260,000 | 0.59% |
| Bellevue Group AG | 1,403,000 | $42,413,000 | 0.59% |
| Logos Global Management LP | 123,465 | $3,732,000 | 0.48% |
| Casdin Capital, LLC | 289,395 | $8,748,000 | 0.39% |
| HighVista Strategies LLC | 16,391 | $496,000 | 0.36% |